DAI Webinar: “Preventing, stabilizing and reversing early Alzheimer’s”

Please consider registering for DAI’s “A Meeting of The Minds” Webinar with guest speaker Dr David Jenkins, on “Preventing, stabilizing and reversing early Alzheimer’s*”

• July 26, 2017 – 5:00 PM (EDT) New York USA
• July 27, 2017 – 7.00 AM Sydney (AEST) Australia

Please note: This event is set in a number of time zones, and has been set up using Sydney, AU – but it is one event for everyone being held on Wednesday, July 26, 2017 (USA/UK/EU) and Thursday, July 27, 2017 (AU/NZ/JP).

About Dave:

Dr Dave Jenkins qualified from Otago University Medical School in New Zealand in 1982. His career includes general practice, senior lectureships at Auckland medical school, executive director for education for an Asian corporate health project, and founding Humanitarian NGO SurfAid and currently is a functional medicine practitioner specializing in stabilisation and reversal of cognitive decline.

Dave has won many awards including the prestigious social entrepreneur award the Rainer Arnold Fellowship and in 2007 and SurfAid was chosen from over 49,000 NGOs was voted “one of the best Non Government Organizations in the world” in 2007 by the World Association of NGOs winning their humanitarian award for that year.

His main work and mission is to dramatically improve the screening, prevention and treatment for all people with cognitive decline in Australasia and beyond. He has trained with Professor Dale Bredesen who has documented reversal in cognitive decline and early Alzheimer’s in over 230 cases using a multifaceted metabolic enhancement program. Dave is now documenting the first reversals of mild to moderate Alzheimer’s in Australasia. Dave is planning to collaborate with Australian scientists and contribute to a multisite trial of “The Bredesen Protocol” in 2017.

About the Webinar:

Learning objectives

1. 1. Successful case studies will demonstrate the programmatic components of reversing cognitive decline using the Bredesen Protocols
2. 2. Learn the current challenges of applying the Bredesen Protocols in Australasia and details of the future controlled trials

Take Home Message

Using a comprehensive and highly personalised Functional Medicine approach Professor Dale Bredesen has reversed over 230 cases of cognitive decline including MCI and early and moderate Alzheimer’s at a 88% success rate including improvements in symptoms, cognitive scores and hippocampal volumes. Seventy five percent of those that had to leave work went back to work. Very early signs in Australasia are also confirming that cognitive decline can be prevented, stabilised and reversed using the Bredesen Protocols.

Register here…

Please note: * I think the word Alzheimer’s rather than dementia has been used in the title of Dave’s presentation, as the research being done by Dale Bredesen and the protocol being discussed is based on patients with MCI or dementia of the Alzheimer’s type. It does not mean people with other types of dementia should not attend, or that the protocol won’t work for us.